Clopidogrel does not optimally inhibit platelet aggregation in patients undergoing percutaneous coronary intervention. Observations from the DEACON study

被引：0
|
作者：
Saucedo, JF
Aude, W
Garza, L
机构：
[1] Univ Oklahoma, HSC, Oklahoma City, OK USA
[2] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2003年 / 92卷 / 6A期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：10L / 11L
页数：2
相关论文
共 50 条
  • [21] Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention
    Mahdieh, Nejat
    Rabbani, Ahmad
    Firouzi, Ata
    Zahedmehr, Ali
    Hoseinimoghaddam, Maryam
    Saedi, Sedigheh
    Sanati, Hamidreza
    Basiri, Hosseinali
    Noohi, Feridoun
    Rabbani, Bahareh
    Maleki, Majid
    CARDIOVASCULAR TOXICOLOGY, 2018, 18 (05) : 482 - 491
  • [22] EFFECT OF TICAGRELOR AND CLOPIDOGREL ON PLATELET AGGREGATION FUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Sui, Z.
    Qu, P.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (02): : 439 - 445
  • [23] Unfractionated heparin increases platelet-monocyte aggregates in vitro and in patients undergoing percutaneous coronary intervention.
    Harding, SA
    Josephs, DH
    Newby, DE
    Dransfield, L
    Haslett, C
    Fox, KAA
    Sarma, J
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (6A): : 157H - 158H
  • [24] Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in prospective data from the INTERACTION study
    Serebruany, V
    Midei, M
    Malinin, A
    Lowry, D
    Oshrine, B
    Steinhubl, S
    Sane, D
    Berger, P
    Tanguay, JF
    O'Connor, C
    Hennekens, C
    CIRCULATION, 2003, 108 (17) : 674 - 674
  • [25] Platelet function varies according to body mass index in patients undergoing percutaneous coronary intervention. Should clopidogrel loading-dose be weight adjusted?
    Angiolillo, DJ
    Fernandez-Ortiz, A
    Bernardo, E
    Barrera, CF
    Viveros, ME
    Vazquez, S
    Soto, H
    Macaya, C
    EUROPEAN HEART JOURNAL, 2002, 23 : 727 - 727
  • [26] Relation between the Change in Mean Platelet Volume and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Intervention
    Koh, Young-Youp
    Kim, Hyung Ho
    Choi, Dong-Hyun
    Lee, Young-Min
    Ki, Young-Jae
    Kang, Seong-Ho
    Park, Geon
    Chung, Joong-Wha
    Chang, Kyong-Sig
    Hong, Soon-Pyo
    CURRENT VASCULAR PHARMACOLOGY, 2015, 13 (05) : 687 - 693
  • [27] Atorvastatin does not inhibit clopidogrel in patients undergoing coronary stenting in prospective data from the interactions of atorvastatin and clopidogrel (INTERACTION) study
    Serebruany, VL
    Midei, MG
    Malinin, AI
    Lowry, DR
    Oshrine, BR
    Steinhubl, SR
    O'Connor, CM
    Hennekens, CH
    AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (6A): : 9L - 10L
  • [28] Clopidogrel loading dose in patients undergoing elective percutaneous coronary intervention
    Lin, Gen-Min
    Li, Yi-Hwei
    Chu, Kai-Min
    Han, Chih-Lu
    HEART, 2011, 97 (13) : 1111 - 1111
  • [29] Correction to: Clopidogrel Pharmacogenetics in Iranian Patients Undergoing Percutaneous Coronary Intervention
    Nejat Mahdieh
    Ahmad Rabbani
    Ata Firouzi
    Ali Zahedmehr
    Maryam Hoseinimoghaddam
    Sedigheh Saedi
    Hamidreza Sanati
    Hosseinali Basiri
    Feridoun Noohi
    Bahareh Rabbani
    Majid Maleki
    Cardiovascular Toxicology, 2018, 18 : 492 - 492
  • [30] The potential interaction of statins and clopidogrel in patients undergoing percutaneous coronary intervention
    Ibrahim, Tahani H.
    Alanazy, Hind S.
    Alharbi, Maram M.
    Ahmed, Safa M.
    INTERNATIONAL JOURNAL OF ADVANCED AND APPLIED SCIENCES, 2021, 8 (03): : 112 - 119
12345